| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sellas Life Sciences Group, Inc. (SLS) has 8 insiders with recent SEC Form 4 filings, including 4 buys and 6 sells. SLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 687.0K | $3.44M | - | |
| VP | 557.8K | $2.79M | - | |
| CFO | 554.3K | $2.78M | - | |
| Dir | 154.4K | $773.5K | - | |
| Dir | 92.9K | $465.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Kalin Katherine Bach | Director | Buy | 63,400 | $1.59 | $100,806.00 | +154.6% | +140.8% | - | |
| Jun 12, 2025 | Van Nostrand Robert L | Director | Buy | 10,000 | $1.48 | $14,800.00 | +96.2% | +13.9% | - | |
| May 30, 2025 | Wasman Jane | Director | Buy | 20,000 | $1.69 | $33,800.00 | +192.3% | +12.3% | - | |
| May 22, 2025 | Kalin Katherine Bach | Director | Buy | 20,000 | $1.80 | $36,000.00 | +95.2% | +5.1% | - | |
| Dec 5, 2022 | Stergiou Angelos M. | President And CEO | Sell | 6,494 | $2.61 | $16,938.30 | -3.9% | -37.7% | -57.5% | |
| Dec 5, 2022 | Burns John Thomas | Senior VP, Finance &CAO | Sell | 1,159 | $2.59 | $3,001.81 | -3.8% | -37.7% | -57.5% | |
| Dec 5, 2022 | Wood Barbara A | EVP, Gen. Counsel, Corp. Sec. | Sell | 2,153 | $2.59 | $5,576.27 | -3.7% | -37.7% | -57.5% | |
| Dec 2, 2021 | Stergiou Angelos M. | President And CEO | Sell | 2,120 | $6.25 | $13,251.91 | -1.7% | -5.0% | -58.6% | |
| Dec 2, 2021 | Wood Barbara A | EVP, Gen. Counsel, Corp. Sec. | Sell | 847 | $6.25 | $5,297.73 | -2.0% | -5.0% | -58.6% | |
| Dec 2, 2021 | Burns John Thomas | VP, Finance &Corp Controller | Sell | 231 | $6.27 | $1,447.75 | -1.3% | -5.0% | -58.6% |